These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36572996)

  • 1. Urinary N-acetyl-β-d-glucosaminidase-creatine ratio is a valuable predictor for advanced diabetic kidney disease.
    Huang Q; Fei X; Zhan H; Gong J; Zhou J; Zhang Y; Ye X; Song Y; Ma J; Wu X
    J Clin Lab Anal; 2023 Jan; 37(1):e24769. PubMed ID: 36572996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive significance of joint plasma fibrinogen and urinary alpha-1 microglobulin-creatinine ratio in patients with diabetic kidney disease.
    Pan L; Wo M; Xu C; Wu Y; Ye Y; Han F; Fei X; Zhu F
    PLoS One; 2022; 17(7):e0271181. PubMed ID: 35802685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus.
    Kim HK; Lee M; Lee YH; Kang ES; Cha BS; Lee BW
    Diabetes Metab J; 2022 Jan; 46(1):104-116. PubMed ID: 34253010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary
    Siddiqui K; Al-Malki B; George TP; Nawaz SS; Rubeaan KA
    3 Biotech; 2019 Mar; 9(3):66. PubMed ID: 30729090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients.
    Uslu S; Efe B; Alataş O; Kebapçi N; Colak O; Demirüstü C; Yörük A
    J Nephrol; 2005; 18(5):559-67. PubMed ID: 16299682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
    Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Lee BW
    Cardiovasc Diabetol; 2017 Jan; 16(1):16. PubMed ID: 28122570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the urinary N-acetyl-beta-D-glucosaminidase/creatinine (NAG/Cr) ratio in discriminating between true and false pyuria in sterile urine bag specimens.
    Lee HN; Jung JY; Hwang S; Park JW; Kim D; Kwak YH; Lee BJ; Lee EJ
    J Pediatr Urol; 2021 Aug; 17(4):442.e1-442.e7. PubMed ID: 34092512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary N-acetyl-beta-D-glucosaminidase and neopterin aid in the diagnosis of rejection and acute tubular necrosis in initially nonfunctioning kidney grafts.
    Kotanko P; Margreiter R; Pfaller W
    Nephron; 2000 Mar; 84(3):228-35. PubMed ID: 10720893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the Urinary N-acetyl-β-D-Glucosaminidase/Creatinine Ratio and Factors of the Metabolic Syndrome.
    Lee E; Lee YK; Kang HJ
    Ann Clin Lab Sci; 2018 Sep; 48(5):627-633. PubMed ID: 30373868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus.
    Bouvet BR; Paparella CV; Arriaga SM; Monje AL; Amarilla AM; Almará AM
    Arq Bras Endocrinol Metabol; 2014 Nov; 58(8):798-801. PubMed ID: 25465599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary N-acetyl-D-glucosaminidase can predict bleeding after a percutaneous kidney biopsy.
    Goto H; Kobayashi Y; Sato H; Fukunaga T; Tanoue K; Yamashiro A; Matsubara H; Oshima N
    BMC Nephrol; 2024 Jul; 25(1):234. PubMed ID: 39039446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination.
    Basturk T; Altuntaş Y; Kurklu A; Aydin L; Eren N; Unsal A
    Ren Fail; 2006; 28(2):125-8. PubMed ID: 16538969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
    Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
    Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
    Wu L; Li XQ; Chang DY; Zhang H; Li JJ; Wu SL; Zhang LX; Chen M; Zhao MH
    Nephrol Dial Transplant; 2020 Feb; 35(2):291-297. PubMed ID: 30357416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].
    Minakami H
    Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Hasegawa J; Sekine A; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):593-601. PubMed ID: 26801478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined detection of urinary biomarkers noninvasively predicts extent of renal injury in patients with early diabetic kidney disease with kidney qi deficiency syndrome: A retrospective investigation.
    Wu W; Meng XJ; Wan BY; Fang QJ; Liu YL; Wang J; Fu Y; Yuan CC; Wang MZ; Chong FL; Wan YG; Shen SM
    Anat Rec (Hoboken); 2023 Dec; 306(12):2945-2957. PubMed ID: 34910381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased urinary N-acetyl-beta-D-glucosaminidase activity in children with hydronephrosis.
    Skalova S; Rejtar P; Kutilek S
    Int Braz J Urol; 2007; 33(1):80-3; discussion 84-6. PubMed ID: 17335604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of UbA52 level in the urine of patients with type 2 diabetes mellitus and diabetic kidney disease.
    Xu X; Dong Y; Liu M; Li Y; Zhang Y
    Nefrologia (Engl Ed); 2021; 41(5):548-555. PubMed ID: 36165137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.